asia-pharma-2018-keynote

3 / 8

Volume 5 Journal of Pharmaceutical Care & Health Systems Asia Pharma 2018
July 18-20, 2018
Page 12
conferenceseries.com
July 18-20, 2018 Melbourne, Australia
15th Asia-Pacific Pharma Congress
Pharmaceutical to nutraceutical: Paradigm shift in healthcare industry
It is generally accepted worldwide that modern pharmaceuticals will remain out of reach of many people and health for
all may only be materialized using adequately assessed nutraceutical/phytomedicinal products. The human has been using
food bioactive and/or herbal medicine for healing purpose from the beginning of human civilization. In recent times, use
of herbal medicine for healthcare has increased steadily all over the world although it was neglected for decades by Western
societies. However, the gaps in relation to the safety, claimed efficacy and quality of herbal products used as herbal medicine,
nutraceuticals, health foods, and cosmetics are being realized and addressed by many companies in their product development
framework. The combination therapy of pharmaceuticals and food bioactive in disease prevention and treatments is one of
the most discussed topics in recent time. The transition of the pharmaceutical industry from its traditional business model is
ongoing and interesting to see how their next blockbuster molecule could be derived through different routes. It is proposed
that the industry is challenged with three interrelated tipping points referring to what the industry sells (service models vs.
therapies), to whom (mass markets vs. niche) and how it should organize itself (making connections vs. integration). The
transition from current high-risk, high-margin business model to low cost high volume nutra business model is dependent on
many factors and advised to move into less regulated markets like animal and consumer health. This presentation will cover:
Paradigm shift in healthcare industry: From pharma to nutra; change of consumer focus: From illness to wellness; peripheral
opportunities also exist for managing chronic lifestyle diseases and ailments; combination therapy of pharmaceuticals and food
bioactive in disease prevention and treatments; health for all target is only possible using adequately assessed nutraceutical/
phytomedicinal products.
Biography
Dilip K Ghosh has received his PhD from India. He is an international speaker, facilitator and author and professionally associated with Nutriconnect, Australia;
Honorary Ambassador, Global Harmonization Initiatives (GHI). He is a fellow of American College of Nutrition (ACN), professional member of Australian Institute
of Food Science & Technology (AIFST), an advisor and executive board member of Health Foods and Dietary Supplements Association (HADSA), India and also
in editorial board of several journals. Ghosh has published more than 90 papers in peer reviewed journals, numerous articles in food and nutrition magazines and
books. His most recent book, “Pharmaceuticals to Nutraceuticals: A shift in disease prevention” under CRC Press, USA has been published in 2016.
Dilip K Ghosh
Nutriconnect, Australia
Dilip K Ghosh, J Pharma Care Health Sys 2018, Volume 5
DOI: 10.4172/2376-0419-C1-025